Quick Answer
Design Therapeutics, Inc. reported Total Assets of $226.20 million for fiscal year 2025.
Design Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $226.20M | -10.3% |
| 2024 | $252.09M | -13.0% |
| 2023 | $289.64M | -15.1% |
| 2022 | $341.14M | -12.7% |
| 2021 | $390.56M | +969.6% |
| 2020 | $36.52M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $211.77M | -19.1% | -5.0% |
| June 30, 2025 | $222.89M | -17.3% | -6.1% |
| March 31, 2025 | $237.47M | -14.8% | -5.8% |
| December 31, 2024 | $252.09M | -13.0% | -3.6% |
| September 30, 2024 | $261.63M | -12.8% | -3.0% |
| June 30, 2024 | $269.58M | -13.5% | -3.3% |
| March 31, 2024 | $278.79M | -14.1% | -3.7% |
| December 31, 2023 | $289.64M | -15.1% | -3.4% |
- Design Therapeutics, Inc. showed a decrease of -10.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Design Therapeutics, Inc.’s total assets has grown by 519.5% (from $36.52 million to $226.20 million).
- The most recent figure is from Design Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: